Rachel is a partner in the Health and Life Sciences Practice at Oliver Wyman.
She has deep experience across the healthcare ecosystem, helping insurance, care delivery, healthcare technology, and biopharmaceutical companies develop and implement growth and diversification strategies. Rachel is passionate about helping clients provide high-quality and affordable experiences to their customers, and she delights in helping organizations do the unexpected to advance their strategies and the health of their communities.
My passion lies in helping clients to identify the perfect blend of customer demand, technological advancements, and internal wherewithal to make bold moves that disrupt and ultimately improve the healthcare industry
Before joining Oliver Wyman, she worked at Collective Health, a health benefits startup backed by venture capital. Rachel has a PhD in Synthetic Chemistry from the University of California, Berkeley, where she worked under the guidance of Professor Dean Toste on developing innovative transition metal-catalyzed organic reactions and synthesizing complex molecules.
She lives by the beach in San Francisco with her husband, daughter, and dog.